Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy
Clinical trial NCT03340675 · COMPLETED
Trial details
- NCT number
- NCT03340675
- Sponsor
- Cumberland Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-19
- Primary completion
- 2024-03-06
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.